Celularity (CELU) Shares Outstanding (2018 - 2025)
Celularity (CELU) posted quarterly Shares Outstanding (Entity) of $28.8 million for Q4 2025, up 27.9% year-over-year from $22.5 million in Q4 2024, and up 2.2% quarter-over-quarter from $28.2 million in Q3 2025.
Celularity (CELU) Shares Outstanding (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Shares Outstanding (Entity) for 8 consecutive years, with $28.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 27.9% year-over-year to $28.8 million; the TTM figure through Dec 2025 stood at $28.8 million (up 27.9% YoY), while the FY2025 annual figure was $28.8 million, up 27.9% from the prior year.
- Shares Outstanding (Entity) improved to $28.8 million in Q4 2025 per CELU's latest filing, from $28.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $28.8 million in Q4 2025 and bottomed at $2.1 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $17.5 million across 5 years, with a median of $18.7 million in 2023.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) soared 1324.24% — and 2025, when it increased 9.79%.
- Celularity's Shares Outstanding (Entity) stood at $6.7 million in 2021, then soared by 122.08% to $14.9 million in 2022, then soared by 30.12% to $19.4 million in 2023, then climbed by 16.35% to $22.5 million in 2024, then climbed by 27.9% to $28.8 million in 2025.
- Business Quant data shows CELU's Shares Outstanding (Entity) at $28.8 million in Q4 2025, $28.2 million in Q3 2025, and $24.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | 25.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.60 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Jun 30, 2025 | 24.02 Mn |
| Mar 31, 2025 | 23.53 Mn |
| Dec 31, 2024 | 21.89 Mn |
| Sep 30, 2024 | 21.98 Mn |
| Jun 30, 2024 | 21.85 Mn |
| Mar 31, 2024 | 21.44 Mn |
| Dec 31, 2023 | 17.81 Mn |
| Sep 30, 2023 | 18.83 Mn |
| Jun 30, 2023 | 17.66 Mn |
| Mar 31, 2023 | 15.54 Mn |
| Dec 31, 2022 | 13.99 Mn |
| Sep 30, 2022 | 14.27 Mn |
| Jun 30, 2022 | 14.02 Mn |
| Mar 31, 2022 | 13.04 Mn |
| Dec 31, 2021 | 6.71 Mn |
| Sep 30, 2021 | 10.64 Mn |
| Jun 30, 2021 | 3.52 Mn |
| Mar 31, 2021 | 2.06 Mn |